Stocks making the biggest moves premarket: Trump Media, Tesla, CoreWeave, Novo Nordisk and more
These are the stocks posting the largest moves in the premarket.
Novo Nordisk released its Q3 2026 financial results on November 4, 2026, showcasing a 4% growth in adjusted sales at constant exchange rates, marking a 27% increase in operating profit to DKK 31.7 billion. The company highlighted the strong performance of its GLP-1 products in driving this growth, with obesity sales up 22% and diabetes sales down 7%.
Novo Nordisk added 1.3 million net patients to its diabetes and obesity treatments in Q3 2026, bringing the total global patient count to approximately 47.8 million. The GLP-1 franchise remains a key growth driver, with Wegovy and Ozempic leading market share in international markets. The company's R&D efforts are also progressing, with seven first-human-dose milestones achieved and ten phase 3 programs underway. Novo Nordisk anticipates regulatory decisions for new therapies in Q4 2026 and early 2027.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
